share_log

上海君澜律师事务所关于浙江海正药业股份有限公司2021年限制性股票激励计划解除限售相关事项之法律意见书

Legal Opinion on the Removal of Restrictions on Zhejiang Hisun Pharmaceutical Co., Ltd.'s Restricted Stock Incentive Plan for 2021 by Shanghai Junlan Law Firm.

SZSI ·  Jul 16
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more